Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02306200 · ClinicalTrials.gov registry record

Cardiovascular Health Improvement Project

A clinical trial of Heart Failure and Cardiovascular Diseases, sponsored by University of Michigan.

Recruiting
Registry status
1
Study location

NCT02306200: Recruiting study of Heart Failure and Cardiovascular Diseases, sponsored by University of Michigan.

NCT02306200 is a study of Heart Failure and Cardiovascular Diseases that is actively recruiting participants, run by University of Michigan. The registry lists this as an open-ended (no fixed target) study. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02306200, a study of Heart Failure and Cardiovascular Diseases, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
open-ended (no fixed target)
Enrollment target
1
Study location

Study Summary

The goal of this project is to establish a biobank of clinical information, DNA, plasma, and aortic tissue samples from patients with cardiovascular disease as well as healthy controls.

Primary Outcome

Establish a biobank of blood, serum, plasma, tissue, and clinical data of patients with any form of aortic disease

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target open-ended (no fixed target)
Start Date 2013-08
Est. Completion 2053-08
University of Michigan

1,327 total trials

What NCT02306200 shows while recruiting

NCT02306200 is an observational study that tracks outcomes without assigning an intervention. The registry lists this as an open-ended (no fixed target) study, common for long-running registries that collect data indefinitely.

The record links to 5 conditions, with Heart Failure appearing as the primary indexed condition, and to 0 interventions.

NCT02306200 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT02306200 about?

NCT02306200 is a clinical study titled "Cardiovascular Health Improvement Project". The goal of this project is to establish a biobank of clinical information, DNA, plasma, and aortic tissue samples from patients with cardiovascular disease as well as healthy controls.

What is the current status of trial NCT02306200?

This trial is currently recruiting. The enrollment target is open-ended (no fixed target). The study started on 2013-08. Estimated completion is 2053-08.

What conditions does trial NCT02306200 study?

This clinical trial studies the following conditions: Heart Failure, Cardiovascular Diseases, Aortic Aneurysm, Aortic Dissection, Bicuspid Aortic Valve (BAV).

Who is sponsoring clinical trial NCT02306200?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02306200 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02306200, the US trial registry maintained by the National Library of Medicine. NCT02306200 (unsized enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.